Abhishek Bhat, MD

Articles by Abhishek Bhat, MD

Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

ByAbhishek Bhat, MD,Sanoj Punnen, MD, MAS

June 19th 2019

In this Point/Counterpoint, Drs. Bhat and Punnen argue that active surveillance can be beneficial for patients with intermediate-risk prostate cancer.

Latest Updated Articles

Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?
June 19th 2019

Abhishek Bhat, MD

Articles by Abhishek Bhat, MD

Point: Should Active Surveillance Be Used for Gleason 3+4 Prostate Cancer?

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

FDA Accepts sNDA for Taletrectinib in ROS1-Positive NSCLC

Achieving a “Functional Cure” With Multiple Myeloma Therapy